v3.25.2
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Royalties and other revenue $ 0 $ 30 $ 0 $ 67
Total revenues 28,866 1,647 30,128 2,777
Operating expenses:        
Cost of sales 33 166 63 197
Research and development 15,747 17,643 31,050 32,015
Selling, general and administrative, including stock-based compensation of $1,575, $3,180, $3,044 and $5,888 respectively 9,350 39,192 20,958 71,252
Total operating expenses 25,130 57,001 52,071 103,464
Income (loss) from operations 3,736 (55,354) (21,943) (100,687)
Interest and other expense  (2,318) (2,211) (4,153) (7,159)
Interest income and other 1,834 4,136 4,053 6,020
Net loss $ 3,252 $ (53,429) $ (22,043) $ (101,826)
Net loss per common share, basic (usd per share) $ 0.01 $ (0.17) $ (0.06) $ (0.37)
Net loss per common share, diluted (usd per share) $ 0.01 $ (0.17) $ (0.06) $ (0.37)
Weighted average common shares outstanding, basic (in shares) 363,294 310,836 362,687 278,113
Weighted average common shares outstanding, diluted (in shares) 363,570 310,836 362,687 278,113
Other comprehensive income (loss):        
Unrealized loss on investments $ (39) $ (143) $ (133) $ (224)
Comprehensive income (loss) 3,213 (53,572) (22,176) (102,050)
Product        
Revenues:        
Net product and licensing revenue 1,322 1,617 2,584 2,710
License        
Revenues:        
Net product and licensing revenue $ 27,544 $ 0 $ 27,544 $ 0